191 related articles for article (PubMed ID: 33612056)
1. Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients - insights on the risk of acquisition and CRE infection.
Freire MP; Carvalho LB; Reusing JO; Spadão F; Lopes MIBF; Nahas WC; David-Neto E; Pierrotti LC
Infect Dis (Lond); 2021 Jun; 53(6):430-439. PubMed ID: 33612056
[TBL] [Abstract][Full Text] [Related]
2. The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae.
Freire MP; de Oliveira Garcia D; Cury AP; Francisco GR; Dos Santos NF; Spadão F; Bueno MFC; Camargo CH; de Paula FJ; Rossi F; Nahas WC; David-Neto E; Pierrotti LC
Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):755-765. PubMed ID: 30680569
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics of carbapenem-resistant
Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
[No Abstract] [Full Text] [Related]
4. Performance of two methods of carbapenem-resistant Enterobacterales surveillance on a kidney transplant ward: selective culture of and real-time PCR directly from rectal swabs.
Freire MP; de Oliveira Garcia D; Lima SG; Pea CRD; Reusing Junior JO; Spadão F; Cury AP; Rossi F; Nahas WC; David-Neto E; Pierrotti LC
Infection; 2022 Dec; 50(6):1525-1533. PubMed ID: 35534755
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
[TBL] [Abstract][Full Text] [Related]
6. Frequency of and risk factors for carbapenem-resistant
Barber KE; Wagner JL; Larry RC; Stover KR
J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33263511
[No Abstract] [Full Text] [Related]
7. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
[TBL] [Abstract][Full Text] [Related]
8. Urinary Tract Infections and Surgical Site Infections due to Carbapenem-Resistant Enterobacteriaceae in Renal Transplant.
Rodrigues Dos Santos BG; Amaral ES; Fernandes PF; Oliveira CM; Rodrigues JL; Perdigão Neto LV; Girão ES
Transplant Proc; 2016; 48(6):2050-5. PubMed ID: 27569943
[TBL] [Abstract][Full Text] [Related]
9. Outbreak of IMP-producing carbapenem-resistant Enterobacter gergoviae among kidney transplant recipients.
Freire MP; de Oliveira Garcia D; Cury AP; Spadão F; Di Gioia TS; Francisco GR; Bueno MF; Tomaz M; de Paula FJ; de Faro LB; Piovesan AC; Rossi F; Levin AS; David Neto E; Nahas WC; Pierrotti LC
J Antimicrob Chemother; 2016 Sep; 71(9):2577-85. PubMed ID: 27197663
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and successful containment of a carbapenem-resistant Enterobacteriaceae outbreak in a Southern Italian Transplant Institute.
Mularoni A; Martucci G; Douradinha B; Campanella O; Hazen B; Medaglia A; Arena G; Gruttadauria S; Tuzzolino F; Arcadipane A; Gioè S; Luca A; Conaldi PG; Grossi P; Gridelli B
Transpl Infect Dis; 2019 Aug; 21(4):e13119. PubMed ID: 31112353
[TBL] [Abstract][Full Text] [Related]
11. Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection After Liver Transplantation: A Multinational Cohort Study.
Giannella M; Freire M; Rinaldi M; Abdala E; Rubin A; Mularoni A; Gruttadauria S; Grossi P; Shbaklo N; Tandoi F; Ferrarese A; Burra P; Fernandes R; Aranha Camargo LF; Asensio A; Alagna L; Bandera A; Simkins J; Abbo L; Halpern M; Santana Girao E; Valerio M; Muñoz P; Fernandez Yunquera A; Statlender L; Yahav D; Franceschini E; Graziano E; Morelli MC; Cescon M; Viale P; Lewis R;
Clin Infect Dis; 2021 Aug; 73(4):e955-e966. PubMed ID: 33564840
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.
van Loon K; Voor In 't Holt AF; Vos MC
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038269
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
[TBL] [Abstract][Full Text] [Related]
14. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.
Satlin MJ; Jenkins SG; Walsh TJ
Clin Infect Dis; 2014 May; 58(9):1274-83. PubMed ID: 24463280
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem-resistant
Ruvinsky S; Voto C; Roel M; Deschutter V; Ferraro D; Aquino N; Reijtman V; Galvan ME; Motto E; García M; Sarkis C; Bologna R
Front Public Health; 2022; 10():983174. PubMed ID: 36091556
[TBL] [Abstract][Full Text] [Related]
17. The Likelihood of Developing a Carbapenem-Resistant
Tamma PD; Kazmi A; Bergman Y; Goodman KE; Ekunseitan E; Amoah J; Simner PJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138574
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem and colistin resistance in children with Enterobacteriaceae infections.
Haytoğlu Z; Gündeşlioğlu ÖÖ; Yıldızdaş D; Kocabaş E; Alabaz D; Horoz ÖÖ
Turk J Pediatr; 2020; 62(5):778-786. PubMed ID: 33108080
[TBL] [Abstract][Full Text] [Related]
19. ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence.
Pilmis B; Scemla A; Join-Lambert O; Mamzer MF; Lortholary O; Legendre C; Zahar JR
Infect Dis (Lond); 2015; 47(10):714-8. PubMed ID: 26024285
[TBL] [Abstract][Full Text] [Related]
20. Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies.
Pouch SM; Satlin MJ
Virulence; 2017 May; 8(4):391-402. PubMed ID: 27470662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
